HUNK
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
hormonally up-regulated Neu-associated kinase | MIM:606532 | Ensembl:ENSG00000142149 | HGNC:HGNC:13326 | PA29563 | 21q22.11 |
GO terms in HUNK
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | IBA | GO:0006468 | protein phosphorylation |
BP | TAS | GO:0007165 | signal transduction |
BP | TAS | GO:0007275 | multicellular organism development |
BP | IBA | GO:0035556 | intracellular signal transduction |
CC | IBA | GO:0005634 | nucleus |
CC | IBA | GO:0005737 | cytoplasm |
MF | IBA | GO:0004674 | protein serine/threonine kinase activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005524 | ATP binding |
Gene expression in normal tissue: HUNK
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in HUNK
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD512 | nutlin 3 | 4 |
iGMDRD424 | Tamatinib | 5 |
iGMDRD523 | Cyanoquinoline, 11 | 7 |
iGMDRD698 | Neratinib | 6 |
iGMDRD177 | Teniposide | 3 |
iGMDRD103 | SN-38 | 4 |
iGMDRD158 | NSC141540 | 3 |
iGMDRD121 | GMX1778 | 2 |
iGMDRD481 | Dactolisib | 3 |
iGMDRD872 | BRD7137 | 3 |
iGMDRD329 | Merck60 | 3 |
iGMDRD366 | PI-103 | 6 |
iGMDRD82 | Quiflapon | 3 |
iGMDRD353 | PD0325901 | 2 |
iGMDRD433 | Lexibulin | 2 |
iGMDRD151 | CHM-1 | 5 |
iGMDRD1008 | SR-II-138A | 3 |
iGMDRD546 | BMS-754807 | 6 |
iGMDRD152 | 179324-69-7 | 1 |
iGMDRD61 | Kinetin riboside | 1 |
iGMDRD138 | PX 12 | 1 |
iGMDRD474 | Avrainvillamide | 4 |
iGMDRD782 | DC-45-A2 | 4 |
iGMDRD885 | Compound 110 | 3 |
iGMDRD318 | PAC-1 | 1 |
iGMDRD309 | 17AAG | 1 |
iGMDRD399 | Selumetinib | 6 |
iGMDRD577 | BIX01294 | 3 |
iGMDRD780 | PP-30 | 6 |
iGMDRD562 | Navitoclax | 6 |
iGMDRD60 | Quinoclamine | 2 |
iGMDRD524 | ISX-9 | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in HUNK